News
The Royal Horticultural Society has named a coral-pink rose "Catherine’s Rose" in honor of the Princess of Wales to raise ...
Roche's Itovebi was the first PI3K inhibitor to get approved as a first-line treatment for breast cancer last year – and new ...
16h
Medpage Today on MSNSurvival Win With Inavolisib-Based Triplet in PIK3CA-Mutated Breast CancerCHICAGO -- Adding the PI3K-pathway inhibitor inavolisib (Itovebi) to palbociclib (Ibrance) and fulvestrant significantly ...
A rose has been named after the Princess of Wales to highlight the healing power of nature. The Royal Horticultural Society ...
3d
News Medical on MSNPotential new treatment to tackle commonest form of childhood cancerA combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic ...
This marks an advancement in the treatment process, potentially saving time for both patients and the hospital. The Royal Marsden NHS Foundation Trust consultant clinical oncologist Dr Susan ...
King Charles has delayed granting Prince William and Princess Kate the authority to issue royal warrants – a centuries-old tradition that gives selected brands the official royal seal of approval.
3d
Emirates News Agency on MSNDubai Health CEO outlines vision for future-ready healthcare systemDubai is shaping a healthcare ecosystem that places people at its heart—one that is innovative, inclusive, and deeply human-centred, said Dr. Amer ...
A rose has been named in honour of the Princess of Wales, to celebrate the healing power of nature. Catherine’s Rose also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results